Fri, Dec 4, 2020
The 52 Week Low is $97.91 set on Mon, Apr 6, 2020.
The 52 Week High is $119.29 set on Mon, Nov 30, 2020.
The All-Time High is $143.21 set on Thu, Dec 31, 2015.
Earnings Per Share
Price To Earnings Ratio
Dividend Payment Date
China Biologic Products Holdings Inc trades on the NASDAQ. CBPO's market cap is 4.6 Billion.
China Biologic Products Holdings Inc is a biopharmaceutical company principally engaged in the research, development, manufacturing and sales of human plasma-based products in China. The company operates its business through two majority owned subsidiaries, Shandong Taibang and Guizhou Taibang. China Biologic's product pipeline includes a variety of dosages across multiple product categories. Its principal products are human albumin and immunoglobulin for intravenous injection. All of the company's products are prescription medicines administered in the form of injections. China Biologic's sales model focuses on direct sales to hospitals and inoculation centers and is complemented by distributor sales.